In stock — order subject to review
PEPTAS research material
Retatrutide 16mg
Retatrutide 16mg modified long-chain peptide research material for qualified laboratory purchasers, subject to item-specific review.
Institutional quantity requirements are reviewed individually. Request a written quotation; enhanced purchaser, end-use, and diversion-risk checks apply.
Need a document before ordering?
Request product or batch information.
Technical and procurement context
Product information
PEPTAS catalog record
About Retatrutide 16mg
Retatrutide designates a modified long-chain peptide research material. This PEPTAS 16mg listing is a non-clinical laboratory reagent supplied solely for documented in-vitro research. The common name does not establish sequence, modification, or counterion. Any human or veterinary administration, consumption, compounding, or other in-vivo application is strictly prohibited.
- Catalog item
- Retatrutide 16mg
- Listed amount
- 16mg
- Material class
- Modified long-chain peptide research material
- Permitted context
- Qualified laboratory research only
Chemical identity
- Synonyms
- LY3437943
- CAS registry number
- 2381089-83-2
- Molecular formula
- C223H343F3N46O70
- Molecular weight
- 4845.4 g/mol (average)
- Physical form
- Lyophilized powder
- Purity stated on packaging
- ≥ 98.8% (HPLC)
- Storage
- Stored and shipped as stated on the packaging and in the order documentation. See Quality control.
Mono-trifluoroacetate salt. The free base is C221H342N46O68; the difference is one equivalent of trifluoroacetic acid retained from purification.
These identifiers describe the catalog material. The molecular weight shown is the average mass calculated from the molecular formula above, cross-checked against the PubChem record where one exists. The purity figure above is the specification printed on the packaging, not a result for any particular lot — batch-specific analytical documentation is confirmed for the actual item or accepted order. See Quality control.
Planning work with this material
Establish required sequence, modification patterns, and analytical records before ordering. Do not assume equivalence across suppliers based on a shared common name; request specific purity, assay, and counterion data for comparisons.
Assess receipt, storage, preparation, and traceability according to validated procedures. Verify the actual specification and isolate any item missing the required documentation.
Documentation and order review
Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order. Request the information your project requires before purchasing; a general catalog page cannot replace an order-specific specification or certificate.
- Confirm purchaser eligibility, destination rules, permits, and institutional approvals.
- Define identity and analytical acceptance criteria before the material is received.
- Inspect the package, identifier, quantity, lot information, and documents on arrival.
- Maintain controlled access, storage, preparation, traceability, and disposal records.
Research-use conditions
Not for human or veterinary use. This material is not a medicine, food, dietary supplement, cosmetic, diagnostic product, or household product. It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition.
Purchasers are responsible for lawful acquisition and use, competent risk assessment, suitable facilities and personnel, appropriate personal protective equipment, validated procedures, security, incident response, and waste disposal. Website information is not medical, veterinary, legal, regulatory, or scientific-protocol advice.
Continue catalog review
